Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Hodgkin Disease × Taxes × 30 days × Clear all

Sponsor

Conditions

Carcinoma, Non-Small-Cell Lung 9 Neoplasm Metastasis 7 Pancreatic Neoplasms 5 Ovarian Neoplasms 5 Fallopian Tube Neoplasms 5 Endometrial Neoplasms 5 Triple Negative Breast Neoplasms 4 Lung Neoplasms 4 Squamous Cell Carcinoma of Head and Neck 3 Oropharyngeal Neoplasms 2 Neoplasms 2 Mouth Neoplasms 2 Laryngeal Neoplasms 2 Hypopharyngeal Neoplasms 2 Colorectal Neoplasms 2 Cholangiocarcinoma 2 Carcinoma, Transitional Cell 2 Carcinoma 2 Breast Neoplasms 2 Anatomic Stage II Breast Cancer AJCC v8 2 Adenocarcinoma of Lung 2 Urinary Bladder Neoplasms 1 Stomach Neoplasms 1 Sinonasal Squamous Cell Carcinoma 1 Rectal Neoplasms 1 Non-Small Cell Lung Cancer Metastatic 1 Nasopharyngeal Carcinoma 1 Melanoma 1 Locally Advanced Cervical Adenocarcinoma 1 Gastric Adenocarcinoma 1

Interventions

Cyclophosphamide 8 fludarabine phosphate 5 fludarabine 5 Magnetic Resonance Spectroscopy 4 Filgrastim 4 Rituximab 3 Nivolumab 3 Gemcitabine 3 Etoposide 3 Doxorubicin 3 Vincristine 2 Vinblastine 2 Specimen Handling 2 Prednisone 2 Mycophenolic Acid 2 Mesna 2 Melphalan 2 Lenalidomide 2 Granulocyte Colony-Stimulating Factor 2 Dacarbazine 2 Cisplatin 2 Brentuximab Vedotin 2 Bleomycin 2 treosulfan 1 tislelizumab 1 thymoglobulin 1 tafasitamab 1 ruxolitinib 1 relatlimab 1 polatuzumab vedotin 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡